Additionally, AEG-1 expression was stronger in cisplatin-resistant ovarian tumors versus cisplatin-sensitive tumors, indicating a potential role of AEG-1 in conferring resistance to cisplatin therapy [59]. Here, MTDH is linked to ovarian neoplasm.